Claritas Pharmaceuticals jobs and careers
San Francisco, CA, United States
About Claritas Pharmaceuticals
Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.
- Employees
- 11 to 50
- Headquarters
- San Francisco
Leadership
The top of Claritas Pharmaceuticals's org chart, with how many people report into each leader.
RF
Robert Farrell
President and CEO
3 reports
IM
Iris Maimon
Director, Drug Development
1 report
NF
Nedira Frenkel
Director, Business Development
Board
AS
Andrew Salzman
Advisor
Jobs at Claritas Pharmaceuticals
No open positions right now. Explore more companies on TheJobsMap.